← Open Payments lookup

AMIT PATEL: Open Payments

NPI 1316208093 · COLDWATER, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,733 in 135 payments from 23 companies in 2025. Trend: 2023 $3,867 · 2024 $4,443 · 2025 $2,733

Food & beverage: $2,733
CompanyPaymentsAmount
AstraZeneca Pharmaceuticals LP15$373
Novo Nordisk Inc9$263
Abbott Laboratories6$257
Bayer Healthcare Pharmaceuticals Inc.11$254
ABBVIE INC.20$211
GlaxoSmithKline, LLC.13$207
Ardelyx, Inc.11$198
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)9$165
Salix Pharmaceuticals, a division of Bausch Health US, LLC6$123
Electromed, Inc.5$120

Products named: Kerendia, TRELEGY ELLIPTA, IBSRELA, Ozempic, FARXIGA, AIRSUPRA, CAPLYTA, ETERNA.

Industry payments across MS — which companies pay providers there.